Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 117.23M | $ 2.64M | 2.26% |
3/31/2025 | $ 41.02M | $ -91.99M | -224.24% |
12/31/2024 | $ 39.67M | $ -105.51M | -266% |
9/30/2024 | $ 69.77M | $ -84.92M | -121.72% |
6/30/2024 | $ 32.48M | $ -65.75M | -202.43% |
3/31/2024 | $ 48.82M | $ -50.9M | -104.27% |
12/31/2023 | $ 61.86M | $ -46.05M | -74.44% |
9/30/2023 | $ 67.47M | $ -39.92M | -59.16% |
6/30/2023 | $ 68.5M | $ -32.49M | -47.43% |
3/31/2023 | $ 71.4M | $ -51.45M | -72.05% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for ZEVRA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -13.94M ] / Equity [ $ -62.33M ]
(=) ROE [ 0% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.49% |
average | 1.52% |
median | 6.45% |
std | 22.72% |